# Multipeptide Vaccine for Advanced Breast Cancer

> **NCT00573495** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 11 (actual)

## Conditions studied

- Breast Neoplasm
- Breast Cancer
- Cancer of the Breast
- Carcinoma, Ductal

## Interventions

- **BIOLOGICAL:** hTERT/Survivin Multi-Peptide Vaccine

## Key facts

- **NCT ID:** NCT00573495
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-07
- **Final completion:** 2013-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573495, "Multipeptide Vaccine for Advanced Breast Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00573495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*